Wall Street Analysts See a 29.28% Upside in Amylyx Pharmaceuticals (AMLX): Can the Stock Really Move This High?Zacks Investment Research • 10/24/25
Has Amylyx Pharmaceuticals (AMLX) Outpaced Other Medical Stocks This Year?Zacks Investment Research • 10/24/25
Kuehn Law Encourages Investors of Amylyx Pharmaceuticals, Inc. to Contact Law FirmPRNewsWire • 10/22/25
AMYLYX INVESTIGATION: Bragar Eagel & Squire, P.C. Urges Amylyx Investors to Contact the Firm Regarding Ongoing Investigation into Amylyx Pharmaceuticals, Inc. on Behalf of Long-Term StockholdersGlobeNewsWire • 10/16/25
Amylyx Pharmaceuticals Announces Pricing of $175 Million Underwritten Public Offering of Common StockBusiness Wire • 09/10/25
Amylyx Pharmaceuticals, Inc. (AMLX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/09/25
Amylyx Pharmaceuticals, Inc. (AMLX) Presents At Citi's Biopharma Back To School Conference TranscriptSeeking Alpha • 09/02/25
Amylyx Pharmaceuticals to Discontinue ORION Program of AMX0035 for Progressive Supranuclear Palsy (PSP)Business Wire • 08/27/25
Amylyx Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 7, 2025Business Wire • 07/31/25
AMYLYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Amylyx Pharmaceuticals, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmGlobeNewsWire • 07/14/25
Amylyx Pharmaceuticals Presents New Exploratory Analyses from Phase 2 and Phase 2b Clinical Trials of Avexitide in Post-Bariatric Hypoglycemia at ENDO 2025Business Wire • 07/13/25
Amylyx Pharmaceuticals to Host Event to Discuss Post-bariatric Hypoglycemia and Avexitide at ENDO 2025Business Wire • 07/08/25
Amylyx Pharmaceuticals, Inc. (AMLX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the InvestigationAccesswire • 06/17/25
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Amylyx Pharmaceuticals, Inc. (AMLX) and Encourages Stockholders to Learn More About the InvestigationAccesswire • 06/15/25
Bronstein, Gewirtz & Grossman, LLC Encourages Amylyx Pharmaceuticals, Inc. (AMLX) Investors to Inquire about Securities InvestigationAccesswire • 06/12/25